Streetbeat News

Products Services

GWAV

Greenwave Technology Solutions, Inc. (GWAV) reported over $9M in revenue for Q4 2023, marking a 10% increase from Q3 2023. The company, which operates metal recycling facilities, expects significant revenue growth in FY 2024 following recent capital investments in equipment and technology to improve operations and margins. These developments come after the commencement of new processing equipment at its Virginia facility.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 5:34 pm

ADM

DWAC

GILD

RVSN

SGMT

VIRI

U.S. stocks traded higher with the Dow Jones gaining around 150 points. Real estate shares led the gains, while consumer discretionary shares fell. The US leading economic index dropped by 0.1% in December, less than the expected 0.5% decline. Sagimet Biosciences' stock surged 94% after positive clinical trial results. Rail Vision's stock jumped 69% following EU certifications for its railway system. Digital World Acquisition Corp's stock rose 26% after Ron DeSantis ended his presidential campaign. Virios Therapeutics' stock plummeted 40% due to plans to advance development for long-COVID treatment. Archer-Daniels-Midland's stock fell 20% amid an investigation into accounting practices. Gilead Sciences' stock dropped 10% after a failed phase 3 study. Oil prices increased by 2.3%, while gold saw a slight decline.

Portfolio Pulse from Avi Kapoor

January 22, 2024 | 5:18 pm

DIS

DKNG

FOX

FOXA

PARA

PARAA

The NFL Playoffs have narrowed down to four teams: the San Francisco 49ers, Detroit Lions, Baltimore Ravens, and Kansas City Chiefs. Media companies like CBS (Paramount Global) and FOX (Fox Corporation) are set to benefit from broadcasting the upcoming conference championship games and Super Bowl LVIII. DraftKings Inc provides updated betting odds for the remaining teams. The Kansas City Chiefs' improved record is highlighted, with Taylor Swift's attendance at games being a notable storyline. ESPN and ABC (Walt Disney Co) will air the NFL Pro Bowl events.

Portfolio Pulse from Chris Katje

January 22, 2024 | 5:15 pm

ELAB

INMB

Elevai Labs, Inc. has entered into a License Agreement with INmune Bio, Inc. to obtain exclusive and non-exclusive rights to develop, manufacture, and commercialize INmune's EMx technology for mesenchymal stromal cells. The agreement includes an upfront payment, scheduled payments, a final technology transfer fee, and a capped nominal royalty on sales of licensed products. Elevai will also supply INmune with hUMSCs at a cost-plus basis after successful manufacturing.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 5:09 pm

AMAM

JNJ

The FDA has granted full approval to Johnson & Johnson's Balversa for certain adult bladder cancer patients, after its initial accelerated approval in April 2019. The Phase 3 THOR study demonstrated Balversa's efficacy in extending overall survival compared to chemotherapy. Additionally, Johnson & Johnson is set to acquire Ambrx Biopharma for approximately $2.0 billion, enhancing its targeted oncology portfolio.

Portfolio Pulse from Vandana Singh

January 22, 2024 | 5:00 pm

GOOG

GOOGL

AI startup ElevenLabs has achieved a $1.1 billion valuation after raising $80 million in a funding round led by Andreessen Horowitz. The company's voice replication software supports over two dozen languages and is eyed for advertising and media. Concerns over deepfakes are addressed by Alphabet Inc's Google and Universal Music through licensing discussions. ElevenLabs is expanding its technology to media production and monetization of AI voices, while also investing in emotional and intonational enhancements. Greg Brockman of OpenAI launched ChatGPT Voice with five human-like voices.

Portfolio Pulse from Anusuya Lahiri

January 22, 2024 | 4:56 pm

RVSN

Rail Vision Ltd (NASDAQ:RVSN) shares surged after the company announced it has received certifications for EU railway standards, which is expected to accelerate the adoption of its Main Line system in the EU market. The certifications demonstrate compliance with EN 50155 and EN 50126, indicating the system's durability and safety for railway operations.

Portfolio Pulse from Adam Eckert

January 22, 2024 | 4:49 pm

AMD

INTC

NVDA

SOXX

KeyBanc Capital Markets analyst John Vinh predicts that Nvidia (NVDA) and AMD (AMD) will outperform in Q4 despite market weakness, driven by strong AI and server demand. AMD is expected to post higher results and guidance, with positive sentiment around its AI accelerator chipset MI300x and server processor Genoa. Nvidia is also anticipated to beat Q4 expectations and issue higher guidance, despite China data center GPU sales decline, due to its position in generative AI demand. Both companies have Overweight ratings from KeyBanc, with price targets of $195 for AMD and $740 for Nvidia. The iShares Semiconductor ETF (SOXX) saw a slight decline.

Portfolio Pulse from Shanthi Rexaline

January 22, 2024 | 4:26 pm

RVSN

Rail Vision's stock (RVSN) is up following the announcement that its Main Line system has received certifications for key EU railway standards.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 4:19 pm

CCL

RCL

Royal Caribbean Cruises Ltd. (NYSE:RCL) has built the world's largest cruise ship, the Icon of the Seas, which will set sail from Miami with week-long cruises to the eastern Caribbean. The ship features unique amenities, including eight neighborhoods, an Aquadome, and various entertainment options. Despite the debate on social media regarding its environmental impact and symbolism of 'late-stage capitalism,' the ship offers affordable vacation options starting at $1,700 per week. RCL's stock has risen over 53% since October and 423% since its COVID-19 low, while Carnival Corp. (NYSE:CCL) has seen less growth, remaining stagnant since April 2020.

Portfolio Pulse from Caleb Naysmith

January 22, 2024 | 4:02 pm